The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex multi-step synthetic process. Early routes focused on protein portion coupling, utilizing solid-phase https://monicaoddl821472.yomoblog.com/47955328/creation-and-study-implementations-of-retatrutide